Countries Australia
Australia's Qbiotics concludes successful $85 million capital raise
Capital raise nets $85 million from Existing Shareholders, Existing Institutional Investors, and cornerstone investor TDM Growth Partners. Fun...
June 28, 2021 | News
Australia's Viraleze™ is highly effective against Alpha, Beta and Gamma COVID variants
The results from the renowned Scripps Research Institute in the US confirm that SPL7013, the active ingredient in Viraleze™, is highly acti...
June 18, 2021 | News
ENA Respiratory secured up to AU$32m investment to Advances COVID-19 Preventative Therapy
Round jointly led by Brandon Capital and Minderoo Foundation with co-investment from Uniseed will support the clinical development of INNA-051 Company a...
June 16, 2021 | News
Sermo Acquires Minter Group to connect the pharmaceutical industry In APAC
Sermo, the world’s leading HCP insights company and the first social media platform for physicians, today announced its acquisition of Australia-base...
June 15, 2021 | News
Viraleze registered for sale in Covid-ravaged India
The announcement came as the world's second most populous country battles a devastating second wave of COVID-19 infections, with over 29 million cases and ...
June 14, 2021 | News
Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited
Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited, for the registration and commercialisation of denosumab, an antir...
June 10, 2021 | News
Australian researchers lead world in successful trial of new cancer treatment
Relatlimab is the first immunotherapy treatment to target LAG-3, a protein in immune cells which reinvigorates and enhances the tumour fighting r...
June 07, 2021 | News
21% were not aware Australian data is accepted by the FDA and other major regulatory authorities
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results o...
June 04, 2021 | Analysis
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
llumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of So...
June 01, 2021 | News
BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® Biosimilar
First clinical trial from BioFactura’s pipeline of high-value biosimilar and biodefense drugs BFI-751: Biosimilar designed to treat people with Cr...
June 01, 2021 | News
World-first multiple sclerosis global image database launched
A world-first global MS image database launched in Australia today complementing MSBase, the largest clinical MS patient registry, to advance MS research w...
May 31, 2021 | News
Avance Clinical Releases Industry Survey Results at BIO Korea 2021
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a rec...
May 27, 2021 | News
Multiply Labs Joins forces with Cytiva to automate cell therapy manufacturing.
Creating a fully automated robotic system will bring industrial scale reliability to cell therapy manufacturing while providing speed and flexibi...
May 26, 2021 | News
Top 3 COVID-19 vaccine questions : Vaccine choice, appointments and blood clots
Intended audience: General public Top 3 questions Why can’t I decide which vac...
May 25, 2021 | Opinion
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
